Comparative investigation of the effect of breviscapine tablet and breviscapine proliposome on thrombosis of rats
LIU Jin-rong,ZHANG Hong-yan,ZHANG Xin-hua,HUANG Liang,WANG Yun,WANG Dan,WANG Han-ming,HAN Dan-dan,WANG Huai-liang
DOI: https://doi.org/10.16695/j.cnki.1006-2947.2010.04.007
2010-01-01
Abstract:Objective We have previously found that the novel preparation breviscapine proliposome (PS) produced stronger effects than breviscapine proliposome(Bre T) in amelioration of cerebral ischemia-reperfusion injury. To study the potential role, a comparative investigation between PS and Bre T on thrombosis and thrombolysis was conducted. Methods The middle cerebral artery occlusion model was made by intraluminal filament technique, the cerebral infarct area was measured by TTC-staining. Carotid arterio-venous bypass thrombus model and vena cava inferior thrombus model were established to investigate antithrombotic effect of PS, carotid artery thrombus was established by exposure to FeCl3 to investigate thrombolytic effect of PS, wet weight of thrombus was measured. Clotting time was determined by capillary method, platelet number was counted before and after PS or Bre T administration, with Bre T as a positive control. Results PS decreased cerebral ischemia-reperfusion infarct area and had higher protective effect compared with Bre T ( P< 0.05). The wet weight of thrombus in PS group and Bre T group was decreased respectively, the inhibition ratio of thrombus and thrombolytic was higher in PS group than in Bre T group. PS and Bre T prolonged coagulation time (P<0.01), but stronger for PS compared with Bre T (P< 0.01). There was no significant difference for platelet number before and after PS or Bre T administration. Conclusion The effects of breviscapine proliposome on inhibition of thrombosis and promotion of thrombolysis are significantly stronger than Bre T in cerebral ischemia-reperfusion injury induced by middle cerebral artery occlusion in rat.
What problem does this paper attempt to address?